Dana dhuwit perusahaan: Pasithea (KTTA)

The development of innovative small molecules for the therapy of psychiatric disorders compels management to maintain strict control over R&D expenses. The cash dynamics for Pasithea Therapeutics (KTTA) on the GURU.Markets daily chart illustrate this balance, where 0.04 serves as the current metric level. The high standing of Pasithea Therapeutics within the scientific community confirms the potential of these investments in the fight against neurodegeneration.
Ringkesan rincian data analitis Pasithea Therapeutics Corp. (KTTA)

This indicator captures the company's immediate liquidity in the form of daily cash balances. Investors must find a balance between excessive capital freezing and the risk of insolvency. By analyzing the history of cash holdings, one can determine the financing cycles of operating activities. For Pasithea Therapeutics (KTTA), this reserve is critical for sustaining costly developments in neurology. A stable cash reserve ensures the uninterrupted protection of patent rights and the commercialization of innovative formulas.